Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Cash generated from core business operations
Latest
$-466.00M
↓ 43% vs avg
Percentile
P7
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-325.71M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-466.00M | -12.5% |
| 2024 | $-414.19M | +12.8% |
| 2023 | $-474.81M | -24.8% |
| 2022 | $-380.46M | -12.3% |
| 2021 | $-338.69M | -156.2% |
| 2020 | $-132.22M | +61.7% |
| 2019 | $-345.38M | -18.9% |
| 2018 | $-290.57M | -14.5% |
| 2017 | $-253.84M | -57.7% |
| 2016 | $-160.97M | - |